nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—ACHE—Biogenic Amine Synthesis—HDC—Gilles de la Tourette syndrome	0.0787	0.109	CbGpPWpGaD
Ephedrine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.0655	0.302	CbGeAlD
Ephedrine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0453	0.0627	CbGpPWpGaD
Ephedrine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0404	0.0559	CbGpPWpGaD
Ephedrine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.0334	0.0462	CbGpPWpGaD
Ephedrine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.0333	0.0461	CbGpPWpGaD
Ephedrine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.0324	0.0449	CbGpPWpGaD
Ephedrine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.0302	0.0418	CbGpPWpGaD
Ephedrine—SLC18A2—Dopaminergic Neurogenesis—SLC6A3—Gilles de la Tourette syndrome	0.0231	0.032	CbGpPWpGaD
Ephedrine—SLC18A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.0231	0.032	CbGpPWpGaD
Ephedrine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.0224	0.031	CbGpPWpGaD
Ephedrine—ACHE—midbrain—Gilles de la Tourette syndrome	0.0169	0.078	CbGeAlD
Ephedrine—SLC18A2—midbrain—Gilles de la Tourette syndrome	0.0165	0.076	CbGeAlD
Ephedrine—SLC6A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.0156	0.0215	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0152	0.0211	CbGpPWpGaD
Ephedrine—ACHE—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.0149	0.0207	CbGpPWpGaD
Ephedrine—SLC6A2—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.0148	0.0204	CbGpPWpGaD
Ephedrine—SLC18A2—nervous system—Gilles de la Tourette syndrome	0.0136	0.0625	CbGeAlD
Ephedrine—SLC18A2—central nervous system—Gilles de la Tourette syndrome	0.0131	0.0602	CbGeAlD
Ephedrine—ADRB2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.013	0.018	CbGpPWpGaD
Ephedrine—ADRB2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0126	0.0174	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0126	0.0174	CbGpPWpGaD
Ephedrine—ADRB2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0117	0.0162	CbGpPWpGaD
Ephedrine—ADRB2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0109	0.0151	CbGpPWpGaD
Ephedrine—ADRA1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0107	0.0149	CbGpPWpGaD
Ephedrine—ACHE—brain—Gilles de la Tourette syndrome	0.0106	0.049	CbGeAlD
Ephedrine—ADRB2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0106	0.0147	CbGpPWpGaD
Ephedrine—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0104	0.0144	CbGpPWpGaD
Ephedrine—SLC18A2—brain—Gilles de la Tourette syndrome	0.0104	0.0478	CbGeAlD
Ephedrine—ADRB2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00987	0.0137	CbGpPWpGaD
Ephedrine—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00971	0.0134	CbGpPWpGaD
Ephedrine—Phenylpropanolamine—SLC6A3—Gilles de la Tourette syndrome	0.0094	0.156	CrCbGaD
Ephedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00904	0.0125	CbGpPWpGaD
Ephedrine—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00902	0.0125	CbGpPWpGaD
Ephedrine—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00876	0.0121	CbGpPWpGaD
Ephedrine—Phentermine—SLC6A3—Gilles de la Tourette syndrome	0.00837	0.139	CrCbGaD
Ephedrine—BCHE—midbrain—Gilles de la Tourette syndrome	0.00833	0.0383	CbGeAlD
Ephedrine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.00828	0.0381	CbGeAlD
Ephedrine—ADRB2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00822	0.0114	CbGpPWpGaD
Ephedrine—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00816	0.0113	CbGpPWpGaD
Ephedrine—Dextroamphetamine—SLC6A3—Gilles de la Tourette syndrome	0.00799	0.133	CrCbGaD
Ephedrine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.00797	0.0367	CbGeAlD
Ephedrine—Pseudoephedrine—SLC6A3—Gilles de la Tourette syndrome	0.00794	0.132	CrCbGaD
Ephedrine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.0077	0.0355	CbGeAlD
Ephedrine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.00741	0.0341	CbGeAlD
Ephedrine—ADRB2—Arf6 signaling events—MET—Gilles de la Tourette syndrome	0.00699	0.00967	CbGpPWpGaD
Ephedrine—ADRB2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00691	0.00956	CbGpPWpGaD
Ephedrine—BCHE—nervous system—Gilles de la Tourette syndrome	0.00684	0.0315	CbGeAlD
Ephedrine—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0068	0.00941	CbGpPWpGaD
Ephedrine—BCHE—central nervous system—Gilles de la Tourette syndrome	0.00659	0.0304	CbGeAlD
Ephedrine—Amphetamine—SLC6A3—Gilles de la Tourette syndrome	0.00644	0.107	CrCbGaD
Ephedrine—SLC6A2—brain—Gilles de la Tourette syndrome	0.00633	0.0292	CbGeAlD
Ephedrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00608	0.00842	CbGpPWpGaD
Ephedrine—Methamphetamine—SLC6A3—Gilles de la Tourette syndrome	0.00597	0.0992	CrCbGaD
Ephedrine—ADRA1A—brain—Gilles de la Tourette syndrome	0.00589	0.0271	CbGeAlD
Ephedrine—Atomoxetine—SLC6A3—Gilles de la Tourette syndrome	0.00587	0.0976	CrCbGaD
Ephedrine—ADRB2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00577	0.00798	CbGpPWpGaD
Ephedrine—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00572	0.00791	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0056	0.00774	CbGpPWpGaD
Ephedrine—BCHE—brain—Gilles de la Tourette syndrome	0.00523	0.0241	CbGeAlD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00507	0.00701	CbGpPWpGaD
Ephedrine—Amphetamine—DRD2—Gilles de la Tourette syndrome	0.00479	0.0796	CrCbGaD
Ephedrine—SLC6A2—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.00439	0.00607	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00411	0.00568	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00388	0.00537	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00365	0.00505	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00345	0.00477	CbGpPWpGaD
Ephedrine—Atomoxetine—HTR2A—Gilles de la Tourette syndrome	0.00337	0.0561	CrCbGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00308	0.00426	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00276	0.00383	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00264	0.00366	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0025	0.00347	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00243	0.00336	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00236	0.00326	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00227	0.00313	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00215	0.00297	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00209	0.00289	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00208	0.00288	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00207	0.00287	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00201	0.00278	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00194	0.00269	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—HDC—Gilles de la Tourette syndrome	0.00191	0.00265	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00187	0.00259	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00177	0.00246	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00172	0.00238	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—HDC—Gilles de la Tourette syndrome	0.00171	0.00236	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.0017	0.00235	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00163	0.00226	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00161	0.00222	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00159	0.0022	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00159	0.00219	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00152	0.0021	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00148	0.00204	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.0014	0.00194	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00136	0.00188	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00135	0.00187	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00131	0.00182	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00131	0.00182	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00122	0.00169	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00112	0.00156	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00104	0.00143	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000923	0.00128	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000896	0.00124	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000856	0.00118	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000839	0.00116	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000835	0.00116	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000814	0.00113	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000764	0.00106	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000758	0.00105	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000742	0.00103	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000694	0.00096	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000691	0.000956	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000673	0.000932	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000627	0.000868	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000585	0.000809	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000531	0.000735	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000495	0.000685	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000484	0.000669	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000481	0.000665	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000448	0.00062	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000439	0.000608	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00041	0.000567	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000398	0.00055	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000371	0.000513	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000314	0.000434	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00026	0.000359	CbGpPWpGaD
